Skip to main content

Table 1 Median numbers of lymph nodes sampled according to the characteristics of the patient, tumor, and grossing pathologist (N = 226 patients with stage III colorectal adenocarcinoma)

From: Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma

Characteristics

Median (MAD)

p value

Sex

 

0.16

 Female

22.0 (8.9)

 

 Male

21.0 (7.4)

 

Tumor site

 

< 0.001

 Rectum

19.0 (5.9)

 

 Colon

25.0 (8.9)

 

Neoadjuvant therapy

 

< 0.001

 No neoadjuvant therapy

24.0 (8.9)

 

 Chemotherapy and/or radiotherapy

18.0 (4.5)

 

Grade

 

0.52

 Well-differentiated or moderately differentiated

22.0 (8.9)

 

 Poorly differentiated

21.5 (7.4)

 

Histologic subtype

 

0.73

 Classic

22.0 (8.9)

 

 Mucinous

21.0 (8.9)

 

Grossing pathologist’s sex

 

0.084

 Female

23.0 (8.9)

 

 Male

20.0 (7.4)

 

Grossing pathologist’s level of training

 

0.010

 Resident

21 (7.4)

 

 Fellow or specialist

22 (8.9)

 
  1. Abbreviations: MAD, median absolute deviation